These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32586225)

  • 1. Response by Tanaka et al to Letter Regarding Article, "Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke".
    Tanaka K; Koga M; Bae HJ
    Stroke; 2020 Aug; 51(8):e164. PubMed ID: 32586225
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Hsieh and Sung Regarding Article, "Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke".
    Hsieh CY; Sung SF
    Stroke; 2020 Aug; 51(8):e163. PubMed ID: 32586223
    [No Abstract]   [Full Text] [Related]  

  • 3. Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.
    Tanaka K; Koga M; Lee KJ; Kim BJ; Park EL; Lee J; Mizoguchi T; Yoshimura S; Cha JK; Lee BC; Nakahara J; Suzuki N; Bae HJ; Toyoda K;
    Stroke; 2020 Apr; 51(4):1150-1157. PubMed ID: 32098607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
    Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
    Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
    Keskar V; McArthur E; Wald R; Harel Z; Zimmerman D; Molnar AO; Garg AX; Lam NN; McCallum MK; Bota SE; Perl J; Sood MM
    Kidney Int; 2017 Apr; 91(4):928-936. PubMed ID: 28017326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Atrial Enlargement and Anticoagulation Status in Patients with Acute Ischemic Stroke and Atrial Fibrillation.
    Dakay K; Chang AD; Hemendinger M; Cutting S; McTaggart RA; Jayaraman MV; Chu A; Panda N; Song C; Merkler A; Gialdini G; Kummer B; Lerario MP; Kamel H; Elkind MSV; Furie KL; Yaghi S
    J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):192-197. PubMed ID: 28918087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
    Hilkens NA; Algra A; Greving JP
    Stroke; 2017 Nov; 48(11):3142-3144. PubMed ID: 28931618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992-2007).
    Shroff GR; Solid CA; Herzog CA
    JAMA Intern Med; 2013 Jan; 173(2):159-60. PubMed ID: 23266657
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulation in patients with acute ischemic stroke and atrial fibrillation--a balance of risks and benefits.
    Beri A; Punnam SR
    Cardiovasc Drugs Ther; 2008 Oct; 22(5):419-25. PubMed ID: 18642133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which risk factors are more associated with ischemic stroke than intracerebral hemorrhage in patients with atrial fibrillation?
    McGrath ER; Kapral MK; Fang J; Eikelboom JW; ó Conghaile A; Canavan M; O'Donnell MJ;
    Stroke; 2012 Aug; 43(8):2048-54. PubMed ID: 22618379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
    Wicke FS; Schaller MA; Karymova K; Beyer M; Müller BS
    BMC Cardiovasc Disord; 2019 Apr; 19(1):94. PubMed ID: 31014253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: Preliminary meta-analysis of cohorts and anticoagulation decision schema.
    Charidimou A; Boulouis G; Shams S; Calvet D; Shoamanesh A;
    J Neurol Sci; 2017 Jul; 378():102-109. PubMed ID: 28566143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Oral Anticoagulants in Octogenarians With Atrial Fibrillation: It Is Never Too Late.
    Russo V; Carbone A; Rago A; Golino P; Nigro G
    J Cardiovasc Pharmacol; 2019 Apr; 73(4):207-214. PubMed ID: 30855404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals.
    Albers GW; Bittar N; Young L; Hattemer CR; Gandhi AJ; Kemp SM; Hall EA; Morton DJ; Yim J; Vlasses PH
    Neurology; 1997 Jun; 48(6):1598-604. PubMed ID: 9191773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, main determinants, and early outcome of patients with atrial fibrillation hospitalized with ischemic stroke: evaluation of the value of risk assessment scores for predicting risk of stroke or major bleeding following anticoagulation therapy.
    Sadeghi R; Parsa Mahjoob M; Asadollahi M; Abbasi Z
    Acta Biomed; 2015 Sep; 86(2):162-9. PubMed ID: 26422431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical Atrial Fibrillation and the Risk of Recurrent Ischemic Stroke.
    Wachter R; Freedman B
    Thromb Haemost; 2021 Jun; 121(6):697-699. PubMed ID: 34020463
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of Ischemic Stroke in High Risk Atrial Fibrillation Patients during Periods of Warfarin Discontinuation for Surgical Procedures.
    Qureshi AI; Jahangir N; Malik AA; Afzal MR; Orfi F; Suri MF
    Cerebrovasc Dis; 2016; 42(5-6):346-351. PubMed ID: 27322535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.